Pharmacokinetics and pharmacodynamics of GH: Dependence on route and dosage of administration

European Journal of Endocrinology

Volumn 156, Issue 6, 2007, Pages 647-653

  Keller, Alexandra ^b   Wu, Zida ^a   Kratzsch, Juergen ^b   Keller, Eberhard ^b   Blum, Werner F ^c   Kniess, Astrid ^d   Preiss, Rainer ^b   Teichert, Jens ^b   Strasburger, Christian J ^a   Bidlingmaier, Martin ^e  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c ELI LILLY AND COMPANY   (United States)

^d Institute of Doping Analysis and Sports Biochemistry   (Germany)

^e UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AREA UNDER THE CURVE; ARTHRALGIA; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DIZZINESS; DOPING; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG MEGADOSE; EDEMA; FEMALE; HORMONE DETERMINATION; HORMONE INHIBITION; HUMAN; HUMAN EXPERIMENT; LOW DRUG DOSE; MALE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NORMAL HUMAN; OPEN STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SIDE EFFECT; SINGLE DRUG DOSE; SUBSTITUTION THERAPY; SWEATING; TIME TO MAXIMUM PLASMA CONCENTRATION; VOMITING;

EID: 34250761851     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-07-0057     Document Type: Article

References (29)

1. Burman P, Johansson AG, Siegbahn A, Vessby B & Kartsson FA. Growth hormone (GH)-deficient men are more responsive to GH replacement than women. Journal of Clinical Endocrinology and Metabolism 1997 82 550-555.
2. Hoffman AR, Kuntze JE, Baptista J, Baum HB, Baumann GP, Biller BM, Clark RV, Cook D, Inzucchi SE, Kleinberg D, Klibanski A, Phillips LS, Ridgway EC, Robbins RJ, Schlechte J, Sharma M, Thorner MO & Vance ML. Growth hormone (GH) replacement therapy in adult-onset GH deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial. Journal of Clinical Endocrinology and Metabolism 2004 89 2048-2056.
3. Attanasio AF, Bates PC, Ho KK, Webb SM, Ross RJ, Strasburger CJ, Bouillon R, Crowe B, Selander K, Valle D, Lamberts SW & Hypoptituitary Control and Complications Study International Advisory Board. Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status - 3-year results from the HypoCCS database. Journal of Clinical Endocrinology and Metabolism 2002 87 1600-1606.
4. Ho KK & Weissberger AJ. Impact of short-term estrogen administration on growth hormone secretion and action: distinct route-dependent effects on connective and bone tissue metabolism. Journal of Bone and Mineral Research 1992 7 821-827.
5. Cook DM. Growth hormone and estrogen: a clinician's approach. Journal of Pediatric Endocrinology and Metabolism 2002 17 (Suppl 4) 1273-1276.
6. Langendonk JG, Meinders AE, Burggraaf J, Frolich M, Roeten CA, Schoemaker RC, Cohen AF & Pijl H. Influence of obesity and body fat distribution on growth hormone kinetics in humans. American Journal of Physiology 1999 277 E824-E829.
7. Hansen TK, Gravjolt CH, Orskov H, Rasmussen MH, Christiansen JS & Jorgensen JO. Dose dependency of the pharmacokinetics and acute lipolytic action of growth hormone. Journal of Clinical Endocrinology and Metabolism 2002 87 4691-4698.
8. Jorgensen JO, Moller J, Moller N, Lauritzen T & Christiansen JS. Pharmacological aspects of growth hormone replacement therapy: route, frequency and timing of administration. Hormone Research 1990 3 (Suppl 4) 77-82.
9. Russo L & Moore WV A comparison of subcutaneous and intramuscularly administration of human growth hormone in the therapy of growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism 1982 55 1003-1006.
10. Kearns GL, Kemp SF & Frindik JP. Single and multiple dose pharmacokinetics of methionyl growth hormone in children with idiopathic growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism 1991 72 1148-1156.
11. Bidlingmaier M, Kim J, Savoy C, Kim MJ, Ebrecht N, de la Motte S & Strasburger CJ. Comparative pharmacokinetics and pharmacodynamics of a new sustained-release growth hormone (GH), LB03002, versus daily GH in adults with GH deficiency. Journal of Clinical Endocrinology and Metabolism 2006 91 2926-2930.
12. Wu Z, Bidlingmaier M, Dall R & Strasburger CJ. Detection of doping with human growth hormone. Lancet 1999 353 895.
13. Bidlingmaier M, Wu Z & Strasburger CJ. Doping with growth hormone. Journal of Pediatric Endocrinology and Metabolism 2001 14 (Suppl 4) 1077-1083.
14. Boguszewski CL, Hynsjo L, Johannsson G, Bengtsson BA & Carlsson LM. 22-kDa growth hormone exclusion assay: a new approach to measurement of non-22-kDa growth hormone isoforms in human blood. European Journal of Endocrinology 1996 135 573-582.
15. Wallace ID, Cuneo RC, Bidlingmaier M, Lundberg PA, Carlson L, Boguszewski CL, Hay J, Borooujerdi M, Cittadini A, Dall R, Rosen T & Strasburger CJ. Changes in non-22-kflodalton (kDa) isoforms of growth hormone (GH) after administration of 22-kDa recombinant human GH in trained adult males. Journal of Clinical Endocrinology and Metabolism 2001 86 1731-1737.
16. Blum WF, Ranke MB, Kietzmann K, Gauggel E, Zeisel HJ & Bierich JR. A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. Journal of Clinical Endocrinology and Metabolism 1990 70 1292-1298.
17. Straume M, Veldhuis JD & Johnson ML. Model-independent quantification of measurement error: empirical estimation of discrete variance function profiles based on standard curves. Methods in Enzymology 1994 240 121-150.
18. Jahreis G, Kauf E, Frohner G & Schmidt HE. Influence of intensive exercise on insulin-like growth factor 1, thyroid and steroid hormones in female gymnasts. Growth Regulation 1991 1 95-99.
19. Tigranian RA, Kalita NF & Davydova NA. Observations on the Soviet/ Canadian transpolar ski trek: status of selected hormones and biologically active compounds. Medicine and Science in Sports and Exercise 1992 33 106-138.
20. Ehrnborg C, Bengtson C & Rosen T. Growth hormone abuse. Baillieres Best Practice and Research. Clinical Endocrinology and Metabolism 2000 14 71-77.
21. Cuneo RC, Judd S, Wallace JD, Perry-Keene D, Burger H, Lim-Tio S, Strauss B, Stockigt J, Topliss D, Alford F, Hew L, Bode H, Conway A, Handelsman D, Dunn S, Boyages S, Cheung NW & Hurley D. The Australian Multicenter Trial of Growth Hormone (GH) treatment in GH-deficient adults. Journal of Clinical Endocrinology and Metabolism 1998 83 107-116.
22. Growth Hormone Research Society. Invited report of a workshop: consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. Journal of Clinical Endocrinology and Metabolism 1998 83 379-381.
23. Root AW, Kemp SF, Rundle AC, Dana K & Attie KM. Effect of long-term recombinant growth hormone therapy in children and adults - the National Cooperative Growth Study, USA, 1985-1994. Journal of Pediatric Endocrinology and Metabolism: 1998 11 403-412.
24. Hansen TK, Møller J, Thomsen K, Frandsen K, Dall R, Jørgensen JO & Christiansen JS. Effects of growth hormone on renal tubular handling of sodium in healthy humans. American Journal of Physiology. Endocrinology and Metabolism 2001 281 E1326-E1332.
25. Laursen T. Clinical pharmacological aspects of growth hormone administration. Growth Hormone and IGF Research 2004 14 16-44.
26. Vahl N, Moller N, Lauritzen T, Christiansen jS & Jorgensen JO. Metabolic effects and pharmacokinetics of a growth hormone pulse in healthy adults: relation to age, sex, and body composition. Journal of Clinical Endocrinology and Metabolism 1997 82 3612-3618.
27. Wallace JD, Ross C, Baxter R, Orskov O, Keay N, Dall R, Rosen T, Jorgensen JO, Cittadini A, Longobardi S, Sacca L, Christiansen JS, Bengtsson B & Sönksen PH. Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration and GH withdrawal in trained adult males: a potential test for GH abuse in sport. Journal of Clinical Endocrinology and Metabolism 1999 84 3591-3598.
28. Giustina A & Veldhius JD. Pathophysiology of the neuroregulation of GH secretion in experimental animals and the human. Endocrine Reviews 1998 19 717-797.
29. Longobardi S, Keay N, Ehrnborg C, Cittadini A, Rosén A, Dall A, Borouierdi MA, Bassett EE, Healy ME, Pentecost C, Wallace JD, Powrie J, Jørgensen JO & Sacca JA. Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: A double blind, placebo-controlled study The GH-2000 study Group. Journal of Clinical Endocrinology and Metabolism 2000 85 1505-1512.